We next examined the relationship between SMARCD1 expression levels in the TCGA cohort: SMARCD1 expression was significantly elevated in bladder cancer specimens compared to adjacent noncancerous tissues (P < 0.0001; Fig. 3H). Here, SMARCD1 is linked to urinary bladder cancer.